Silent cerebral infarct in patients with sickle cell anemia;Infarto cerebral silente en pacientes con anemia falciforme

Revista de Neurologia

Volumn 35, Issue 8, 2002, Pages 716-719

  Ferrer Ocando, Olmedo ^a   Plumacher Rincon Z ^a   Arteaga Vizcaino M ^a   Weir Medina, J ^a   Hernandez Pernia A ^a  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

Author keywords

Magnetic resonance imaging; Neurological alterations; Sickle cell anemia; Silent cerebral infarct; Stroke

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRAIN INFARCTION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITION; CONSCIENCE; FEMALE; HUMAN; INCIDENCE; LANGUAGE; MALE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; SICKLE CELL ANEMIA; STROKE;

EID: 0037121135     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3508.2002336     Document Type: Article

References (26)

1. Adams RJ. Lessons from the Stroke Prevention Trial in Sickle Cell Anemia (STOP) Study. J Child Neurol 2000; 15: 344-9.
2. Adams RJ. Neurologic complications. In Embyry SH, Hebbel RP, Mohandas N, Steinberd M, eds. Sickle cell disease basic principles and clinical practice. New York: Raven Press; 1994.
3. Adams RJ, Mckie VC, Hsu L, Files B, Gallagher D, Abdullak K, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results of transcranial Doppler ultrasonography. N Engl J Med 1998; 339: 5-11.
4. Ohene-Frempong K. Stroke in sickle cell disease: demographic clinical, and therapeutic considerations. Semin Hematol 1998; 28: 213-9.
5. Adams RJ, Mckie VC, Nichols F. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med 1992; 326: 605-10.
6. Hinton RC. Current concepts of thrombosis: prevalent trends for diagnosis and management. Med Clin N Am 1998; 82: 240-54.
7. Pavlakis SG. Neurologic complication of sickle cell disease. Adv Pediatr 1989; 36: 247-76.
8. Hinton R. Current concepts of thrombosis: prevalent trends for diagnosis and management. Thrombosis and cerebrovascular disease. Med Clin N Am 1998; 82: 523-44.
9. Hernández PA. Hemorragia cerebral y crisis hipertensiva. Una propuesta clínica. Rev Invest Clin 2001; 42: 221-3.
10. Morán CJ, Siegel MJ, DeBaun MR. Sickle cell disease: imaging of cerebrovascular complications. Radiology 1998; 206: 311-21.
11. Pegelow CH, Adams RJ, Mckie V, Abboud M, Berman B, Miller S, et al. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr 1995; 126: 896-9.
12. Steinberg MH. Management of sickle cell disease. N Engl J Med 1999; 340: 1021-30.
13. Seiberth JJ, Miller SF, Kirby RS, Bectron D, James CH, Glasier CH, et al. Cerebrovascular disease in symptomatic and asymptomatic patients wit sickle cell anemia: screening with duplex transcranial Doppler us-correlation with MR imaging and MR angiography. Radiology 1993; 189: 457-66.
14. Torres-Guerra E, Torres-Guerra T, Valbuena G, Arteaga-Vizcaíno M, Soto L. Frecuencia de anemia falciforme en la población de Cuatro Bocas, parroquia Ricaurte, municipio Mara, Estado Zulia, Venezuela. Rev Invest Clin 1993; 34: 99-105.
15. Kinner TR, Sleeper LA, Wang WC, Zimmerman RA, Pegelow CH, Ohene-Fremppong K. Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. Pediatrics 1999; 103: 380-92.
16. Stockman J, Nicro MA, Mishkin M, Oski FA. Occlusion of large cerebral vessels in sickle-cell anemia. N Engl J Med 1972; 287: 846-9.
17. Ohene-Frempong K, Weinwe SJ, Sleeper LA, Miller ST, Emburry S, Moohr JW, et al. Study of sickle cell disease: cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998; 91: 288-94.
18. Wang WC, Gallagher DM, Pegelow CH, Wright EC, Vichinsky EP, Abboud MR, et al. Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous systems in children with sickle cell disease. J Pediatr Hematol Oncol 2000; 22: 335-44.
19. Wang WC, Ñounar E, Tonkin I, Mulhern R, Langston JW, Day SW, et al. High risk of recurrent stroke years of transfusion therapy in patients with sickle cell disease. J Pediatr 1991; 118: 377-82.
20. Neonato M, Guilloud-Bataille M, Beauvais P, Bégué P, Belloy M, Benkerrou M, et al. Acute clinical events in 299 homozygous sickle cell patients living in France. French Study Group on Sickle Cell Disease. Eur J Haematol 2000; 65: 155-64.
21. Miller ST, Maccklin EA, Pegelow CH, Kinney TR, Sleeper LA, Bello JA, et al. Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease. Am J Neuroradiol 2001; 139: 233-42.
22. Mosser FG, Miller S, Bello JA. The spectrum of brain MR abnormalities in sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease. Am J Neuroradiol 1996; 17: 965-72.
23. Oguro H, Okada K, Yamaguchi S, Kobashi S. A six year follow-up study on the influence of silent ischemic brain lesions on cognitive function and brain atrophy in elderly people. Nippon Ronen Igakkai Zasshi 2000; 37: 298-303.
24. Pavlakis SG, Bello S, Prohounik J, Sutton M, Ince O, Mohr JP. Brain infarction in sickle cell anemia magnetic resonance imaging correlates. Ann Neurol 1998; 23: 125-30.
25. Schatz J, Brown RT, Pascual JM, Hsu L, DeBraun MR. Poor school and cognitive functioning with silent cerebral infarcts and sickle cell disease. Neurology 2001; 56: 1109-11.
26. Wiebers D, Dale A, Kokmen E, Swanson. Mayo Clinic examination in neurology. 7 ed. Rochester, Minnesota: Mosby; 1998. p. 323-7.